Helius Medical Technologies, Inc.
HSDT
$6.27
$0.0450.72%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -80.70% | -69.35% | 14.63% | -69.70% | -29.92% |
| Total Other Revenue | -9.09% | 0.00% | 0.00% | 0.00% | -8.33% |
| Total Revenue | -76.37% | -63.70% | 13.43% | -64.34% | -28.91% |
| Cost of Revenue | -18.64% | -1.63% | 71.11% | 0.00% | -35.87% |
| Gross Profit | -182.81% | -700.00% | -104.55% | -209.09% | -11.11% |
| SG&A Expenses | -0.41% | 13.71% | 33.46% | 29.78% | -4.36% |
| Depreciation & Amortization | -- | -- | -62.50% | -78.13% | -81.58% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -2.52% | 14.33% | 36.93% | 31.37% | -0.66% |
| Operating Income | -1.59% | -17.42% | -38.33% | -35.94% | -1.58% |
| Income Before Tax | -509.99% | -52.54% | -275.89% | -0.63% | 2.18% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -509.99% | -52.54% | -275.89% | -0.63% | 2.18% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -509.99% | -52.54% | -275.89% | -0.63% | 2.18% |
| EBIT | -1.59% | -17.42% | -38.33% | -35.94% | -1.58% |
| EBITDA | 19.08% | -17.74% | -39.10% | -37.33% | -2.62% |
| EPS Basic | -- | -- | -- | -- | -- |
| Normalized Basic EPS | -- | -- | -- | -- | -- |
| EPS Diluted | -- | -- | -- | -- | -- |
| Normalized Diluted EPS | -- | -- | -- | -- | -- |
| Average Basic Shares Outstanding | -- | -- | -- | -- | -- |
| Average Diluted Shares Outstanding | -- | -- | -- | -- | -- |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |